Mechanisms underlying the pathogenesis of isolated impaired glucose tolerance in humans

Ron T. Varghese, Chiara Dalla Man, Anu Sharma, Ivan Viegas, Cristina Barosa, Catia Marques, Meera Shah, John M. Miles, Robert A. Rizza, John G. Jones, Claudio Cobelli, Adrian Vella

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Context: Prediabetes is a heterogeneous disorder classified on the basis of fasting glucose concentrations and 2-hour glucose tolerance. Objective:Wesought to determine the relative contributions of insulin secretion and action to the pathogenesis of isolated impaired glucose tolerance (IGT). Design: The study consisted of an oral glucose tolerance test and a euglycemic clamp performed in two cohorts matched for anthropometric characteristics and fasting glucose but discordant for glucose tolerance. Setting: An inpatient clinical research unit at an academic medical center. Patients or Other Participants: Twenty-five subjects who had normal fasting glucose (NFG) and normal glucose tolerance (NGT) and 19 NFG/IGT subjects participated in this study. Intervention(s): Subjects underwent a seven-sample oral glucose tolerance test and a 4-hour euglycemic, hyperinsulinemic clamp on separate occasions. Glucose turnover during the clamp was measured using tracers, and endogenous hormone secretion was inhibited by somatostatin. Main Outcome Measures: We sought to determine whether hepatic glucose metabolism, specifically the contribution of gluconeogenesis to endogenous glucose production, differed between subjects with NFG/NGT and those with NFG/IGT. Results: Endogenous glucose production did not differ between groups before or during the clamp. Insulin-stimulated glucose disappearance was lower in NFG/IGT (24.6 ± 2.2 vs 35.0 ± ± 3.6 ±mol/kg/min; P=.03). The disposition index was decreased in NFG/IGT (681±102 vs 2231±413± 10-14 dL/kg/min2 per pmol/L; P < .001). Conclusions: We conclude that innate defects in the regulation of glycogenolysis and gluconeogenesis do not contribute to NFG/IGT. However, insulin-stimulated glucose disposal is impaired, exacerbating defects in β-cell function.

Original languageEnglish (US)
Pages (from-to)4816-4824
Number of pages9
JournalJournal of Clinical Endocrinology and Metabolism
Volume101
Issue number12
DOIs
StatePublished - Dec 1 2016

Fingerprint

Glucose Intolerance
Glucose
Fasting
Clamping devices
Glucose Clamp Technique
Gluconeogenesis
Insulin
Glucose Tolerance Test
Glycogenolysis
Prediabetic State

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Biochemistry
  • Endocrinology
  • Clinical Biochemistry
  • Biochemistry, medical

Cite this

Mechanisms underlying the pathogenesis of isolated impaired glucose tolerance in humans. / Varghese, Ron T.; Man, Chiara Dalla; Sharma, Anu; Viegas, Ivan; Barosa, Cristina; Marques, Catia; Shah, Meera; Miles, John M.; Rizza, Robert A.; Jones, John G.; Cobelli, Claudio; Vella, Adrian.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 101, No. 12, 01.12.2016, p. 4816-4824.

Research output: Contribution to journalArticle

Varghese, RT, Man, CD, Sharma, A, Viegas, I, Barosa, C, Marques, C, Shah, M, Miles, JM, Rizza, RA, Jones, JG, Cobelli, C & Vella, A 2016, 'Mechanisms underlying the pathogenesis of isolated impaired glucose tolerance in humans', Journal of Clinical Endocrinology and Metabolism, vol. 101, no. 12, pp. 4816-4824. https://doi.org/10.1210/jc.2016-1998
Varghese, Ron T. ; Man, Chiara Dalla ; Sharma, Anu ; Viegas, Ivan ; Barosa, Cristina ; Marques, Catia ; Shah, Meera ; Miles, John M. ; Rizza, Robert A. ; Jones, John G. ; Cobelli, Claudio ; Vella, Adrian. / Mechanisms underlying the pathogenesis of isolated impaired glucose tolerance in humans. In: Journal of Clinical Endocrinology and Metabolism. 2016 ; Vol. 101, No. 12. pp. 4816-4824.
@article{df0ee4981a4e48d3bdfb3c4982efbd69,
title = "Mechanisms underlying the pathogenesis of isolated impaired glucose tolerance in humans",
abstract = "Context: Prediabetes is a heterogeneous disorder classified on the basis of fasting glucose concentrations and 2-hour glucose tolerance. Objective:Wesought to determine the relative contributions of insulin secretion and action to the pathogenesis of isolated impaired glucose tolerance (IGT). Design: The study consisted of an oral glucose tolerance test and a euglycemic clamp performed in two cohorts matched for anthropometric characteristics and fasting glucose but discordant for glucose tolerance. Setting: An inpatient clinical research unit at an academic medical center. Patients or Other Participants: Twenty-five subjects who had normal fasting glucose (NFG) and normal glucose tolerance (NGT) and 19 NFG/IGT subjects participated in this study. Intervention(s): Subjects underwent a seven-sample oral glucose tolerance test and a 4-hour euglycemic, hyperinsulinemic clamp on separate occasions. Glucose turnover during the clamp was measured using tracers, and endogenous hormone secretion was inhibited by somatostatin. Main Outcome Measures: We sought to determine whether hepatic glucose metabolism, specifically the contribution of gluconeogenesis to endogenous glucose production, differed between subjects with NFG/NGT and those with NFG/IGT. Results: Endogenous glucose production did not differ between groups before or during the clamp. Insulin-stimulated glucose disappearance was lower in NFG/IGT (24.6 ± 2.2 vs 35.0 ± ± 3.6 ±mol/kg/min; P=.03). The disposition index was decreased in NFG/IGT (681±102 vs 2231±413± 10-14 dL/kg/min2 per pmol/L; P < .001). Conclusions: We conclude that innate defects in the regulation of glycogenolysis and gluconeogenesis do not contribute to NFG/IGT. However, insulin-stimulated glucose disposal is impaired, exacerbating defects in β-cell function.",
author = "Varghese, {Ron T.} and Man, {Chiara Dalla} and Anu Sharma and Ivan Viegas and Cristina Barosa and Catia Marques and Meera Shah and Miles, {John M.} and Rizza, {Robert A.} and Jones, {John G.} and Claudio Cobelli and Adrian Vella",
year = "2016",
month = "12",
day = "1",
doi = "10.1210/jc.2016-1998",
language = "English (US)",
volume = "101",
pages = "4816--4824",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "12",

}

TY - JOUR

T1 - Mechanisms underlying the pathogenesis of isolated impaired glucose tolerance in humans

AU - Varghese, Ron T.

AU - Man, Chiara Dalla

AU - Sharma, Anu

AU - Viegas, Ivan

AU - Barosa, Cristina

AU - Marques, Catia

AU - Shah, Meera

AU - Miles, John M.

AU - Rizza, Robert A.

AU - Jones, John G.

AU - Cobelli, Claudio

AU - Vella, Adrian

PY - 2016/12/1

Y1 - 2016/12/1

N2 - Context: Prediabetes is a heterogeneous disorder classified on the basis of fasting glucose concentrations and 2-hour glucose tolerance. Objective:Wesought to determine the relative contributions of insulin secretion and action to the pathogenesis of isolated impaired glucose tolerance (IGT). Design: The study consisted of an oral glucose tolerance test and a euglycemic clamp performed in two cohorts matched for anthropometric characteristics and fasting glucose but discordant for glucose tolerance. Setting: An inpatient clinical research unit at an academic medical center. Patients or Other Participants: Twenty-five subjects who had normal fasting glucose (NFG) and normal glucose tolerance (NGT) and 19 NFG/IGT subjects participated in this study. Intervention(s): Subjects underwent a seven-sample oral glucose tolerance test and a 4-hour euglycemic, hyperinsulinemic clamp on separate occasions. Glucose turnover during the clamp was measured using tracers, and endogenous hormone secretion was inhibited by somatostatin. Main Outcome Measures: We sought to determine whether hepatic glucose metabolism, specifically the contribution of gluconeogenesis to endogenous glucose production, differed between subjects with NFG/NGT and those with NFG/IGT. Results: Endogenous glucose production did not differ between groups before or during the clamp. Insulin-stimulated glucose disappearance was lower in NFG/IGT (24.6 ± 2.2 vs 35.0 ± ± 3.6 ±mol/kg/min; P=.03). The disposition index was decreased in NFG/IGT (681±102 vs 2231±413± 10-14 dL/kg/min2 per pmol/L; P < .001). Conclusions: We conclude that innate defects in the regulation of glycogenolysis and gluconeogenesis do not contribute to NFG/IGT. However, insulin-stimulated glucose disposal is impaired, exacerbating defects in β-cell function.

AB - Context: Prediabetes is a heterogeneous disorder classified on the basis of fasting glucose concentrations and 2-hour glucose tolerance. Objective:Wesought to determine the relative contributions of insulin secretion and action to the pathogenesis of isolated impaired glucose tolerance (IGT). Design: The study consisted of an oral glucose tolerance test and a euglycemic clamp performed in two cohorts matched for anthropometric characteristics and fasting glucose but discordant for glucose tolerance. Setting: An inpatient clinical research unit at an academic medical center. Patients or Other Participants: Twenty-five subjects who had normal fasting glucose (NFG) and normal glucose tolerance (NGT) and 19 NFG/IGT subjects participated in this study. Intervention(s): Subjects underwent a seven-sample oral glucose tolerance test and a 4-hour euglycemic, hyperinsulinemic clamp on separate occasions. Glucose turnover during the clamp was measured using tracers, and endogenous hormone secretion was inhibited by somatostatin. Main Outcome Measures: We sought to determine whether hepatic glucose metabolism, specifically the contribution of gluconeogenesis to endogenous glucose production, differed between subjects with NFG/NGT and those with NFG/IGT. Results: Endogenous glucose production did not differ between groups before or during the clamp. Insulin-stimulated glucose disappearance was lower in NFG/IGT (24.6 ± 2.2 vs 35.0 ± ± 3.6 ±mol/kg/min; P=.03). The disposition index was decreased in NFG/IGT (681±102 vs 2231±413± 10-14 dL/kg/min2 per pmol/L; P < .001). Conclusions: We conclude that innate defects in the regulation of glycogenolysis and gluconeogenesis do not contribute to NFG/IGT. However, insulin-stimulated glucose disposal is impaired, exacerbating defects in β-cell function.

UR - http://www.scopus.com/inward/record.url?scp=85003545634&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85003545634&partnerID=8YFLogxK

U2 - 10.1210/jc.2016-1998

DO - 10.1210/jc.2016-1998

M3 - Article

C2 - 27603902

AN - SCOPUS:85003545634

VL - 101

SP - 4816

EP - 4824

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 12

ER -